We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.48B
AUM Growth
+$121M
Cap. Flow
+$68.3M
Cap. Flow %
1.96%
Top 10 Hldgs %
12.54%
Holding
1,594
New
179
Increased
532
Reduced
584
Closed
199

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$8.12M
2
KMI icon
Kinder Morgan
KMI
+$7.34M
3
ILMN icon
Illumina
ILMN
+$6.91M
4
DD icon
DuPont de Nemours
DD
+$6.77M
5
NVGS icon
Navigator Holdings
NVGS
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 12.04%
2 Industrials 10.15%
3 Energy 9.83%
4 Financials 9.31%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMLP icon
526
Dorchester Minerals
DMLP
$1.33B
$1.32M 0.04%
51,599
+32,949
+177% +$872K
SRCL
527
DELISTED
Stericycle Inc
SRCL
$1.3M 0.04%
9,957
+657
+7% +$82.7K
HQH
528
abrdn Healthcare Investors
HQH
$1.25B
$1.3M 0.04%
42,247
+10,577
+33% +$318K
ETP
529
DELISTED
Energy Transfer Partners, L.P.
ETP
$1.29M 0.04%
30,983
+1,329
+4% +$61.2K
IOO icon
530
iShares Global 100 ETF
IOO
$8.9B
$1.29M 0.04%
33,924
+412
+1% +$15.8K
BHI
531
DELISTED
Baker Hughes
BHI
$1.29M 0.04%
23,043
-2,529
-10% -$143K
BAB icon
532
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$1.29M 0.04%
42,353
+1,514
+4% +$45.5K
FXO icon
533
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$1.29M 0.04%
55,328
+21,573
+64% +$487K
WBMD
534
DELISTED
WebMD Health Corp.
WBMD
$1.28M 0.04%
32,475
+7,173
+28% +$276K
LUMN icon
535
Lumen
LUMN
$6.71B
$1.28M 0.04%
32,263
-1,106
-3% -$44.3K
AWK icon
536
American Water Works
AWK
$27B
$1.27M 0.04%
23,857
LULU icon
537
lululemon athletica
LULU
$13.5B
$1.27M 0.04%
22,746
+2,149
+10% +$98K
EPAY
538
DELISTED
Bottomline Technologies Inc
EPAY
$1.27M 0.04%
50,227
+37,820
+305% +$974K
AVNS
539
DELISTED
Avanos Medical
AVNS
$1.25M 0.04%
+27,395
New +$1.08M
AUXL
540
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$1.25M 0.04%
36,213
-22,840
-39% -$745K
LTXB
541
DELISTED
LegacyTexas Financial Group Inc
LTXB
$1.24M 0.04%
52,053
+24,163
+87% +$599K
SJM icon
542
J.M. Smucker
SJM
$12.9B
$1.24M 0.04%
12,266
-1,562
-11% -$158K
ADT
543
DELISTED
ADT Corp
ADT
$1.24M 0.04%
34,186
+27,000
+376% +$929K
DEO icon
544
Diageo
DEO
$49B
$1.23M 0.04%
10,738
-763
-7% -$88.7K
ETV
545
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.72B
$1.23M 0.04%
87,100
+10,750
+14% +$159K
MPC icon
546
Marathon Petroleum
MPC
$92B
$1.23M 0.04%
27,134
+1,230
+5% +$54.1K
AMAT icon
547
Applied Materials
AMAT
$409B
$1.22M 0.04%
49,121
+3,726
+8% +$84.1K
XLI icon
548
State Street Industrial Select Sector SPDR ETF
XLI
$32.9B
$1.22M 0.04%
21,596
+3,767
+21% +$207K
DRI icon
549
Darden Restaurants
DRI
$23.5B
$1.22M 0.04%
23,299
-1,557
-6% -$75.4K
BGG
550
DELISTED
Briggs & Stratton Corp.
BGG
$1.21M 0.03%
59,413
-3,036
-5% -$59.6K

Similar funds

Oppenheimer & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Oppenheimer & Co held 1,594 positions worth $3.48B, up 3.6% from $3.36B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q4 2014 filing shows 179 new, 532 increased, 584 reduced and 199 closed positions. Its largest new stake was First American: 99,605 shares worth $3.38M. The largest sale was IBM, an estimated $5.56M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Energy.

  • Oppenheimer & Co's largest Q4 2014 buy was First American: 99,605 shares worth $3.38M.
  • Oppenheimer & Co added most to Alibaba in Q4 2014, an estimated $8.12M increase.
  • Oppenheimer & Co's biggest Q4 2014 reduction was IBM, cutting an estimated $5.56M.
  • Oppenheimer & Co fully exited Tesla in Q4 2014, selling an estimated $4.59M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.48B portfolio in Q4 2014.
  • Oppenheimer & Co opened 179 new positions and closed 199 in Q4 2014.
  • Oppenheimer & Co's portfolio value rose 3.6% quarter-over-quarter to $3.48B.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.